CAPITOL HILL CONSULTING GROUP for PURDUE PHARMA LLP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety; Food and Drug Administration Amendments Act of 2007 (P.L. 110-85); Stop Oxy Abuse Act (H.R. 4956)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Pharmacy PHA
Controlled Drug Substances Act (21 USC 13)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Medicare/Medicaid MMM
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; America's Affordable Health Choices Act of 2009 (H.R. 3200); America's Healthy Future Act of 2009; Affordable Healthcare for America Act (H.R. 3962); Patient Protection and Affordable Care Act (H.R. 3590)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.